NCT01374451 - Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET | Biotech Hunter

Enrollment

160

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions

Islet Cell Tumor

Interventions

DRUG

Everolimus

Everolimus was supplied as tablets of 5 mg strength, blister-packed under aluminum foil in units of 10 tablets

DRUG

Pasireotide LAR

Pasireotide LAR intra-muscular depot injections were supplied as a powder in vials containing 20 mg and 40 mg with ampoules containing 2 mL of vehicle (for reconstitution).

Trial Locations (47)

1062

Novartis Investigative Site, Budapest

1070

Novartis Investigative Site, Brussels

1085

Novartis Investigative Site, Budapest

1200

Novartis Investigative Site, Brussels

2065

Novartis Investigative Site, St Leonards

3000

Novartis Investigative Site, Leuven

4029

Novartis Investigative Site, Herston

4032

Novartis Investigative Site, Debrecen

7100

Novartis Investigative Site, Haine-Saint-Paul

8000

Novartis Investigative Site, Aarhus

9000

Novartis Investigative Site, Ghent

10330

Novartis Investigative Site, Bangkok

10467

Montefiore Medical Center MMC, The Bronx

10700

Novartis Investigative Site, Bangkok

13353

Novartis Investigative Site, Berlin

13385

Novartis Investigative Site, Marseille

20141

Novartis Investigative Site, Milan

28041

Novartis Investigative Site, Madrid

33075

Novartis Investigative Site, Bordeaux

34303

Novartis Investigative Site, Istanbul

40138

Novartis Investigative Site, Bologna

41100

Novartis Investigative Site, Modena

69437

Novartis Investigative Site, Lyon

81675

Novartis Investigative Site, München

92110

Novartis Investigative Site, Clichy

94805

Novartis Investigative Site, Villejuif

97239

Oregon Health & Science University Knight Cancer Institute, Portland

02115

Dana Farber Cancer Institute SC-2, Boston

77030-4009

University of Texas/MD Anderson Cancer Center UT MD Anderson Cancer Ctr, Houston

C1264AAA

Novartis Investigative Site, Buenos Aires

C1426ANZ

Novartis Investigative Site, Caba

20230-130

Novartis Investigative Site, Rio de Janeiro

01246-000

Novartis Investigative Site, São Paulo

M5G 2M9

Novartis Investigative Site, Toronto

H1T 2M4

Novartis Investigative Site, Montreal

DK-2200

Novartis Investigative Site, Copenhagen N

812-8582

Novartis Investigative Site, Fukuoka

3015 CE

Novartis Investigative Site, Rotterdam

Unknown

Novartis Investigative Site, Grafton, Auckland

08035

Novartis Investigative Site, Barcelona

08907

Novartis Investigative Site, L'Hospitalet de Llobregat

SE-221 85

Novartis Investigative Site, Lund

SE-751 85

Novartis Investigative Site, Uppsala

06100

Novartis Investigative Site, Ankara

CB2 2QQ

Novartis Investigative Site, Cambridge

G12 0YN

Novartis Investigative Site, Glasgow

M20 9BX

Novartis Investigative Site, Manchester